Anti-cancer drug price control brings significant savings for consumers, totaling Rs 3,540 crore.
Read More
Giredestrant launch details: Is it the best move for Roche?
Giredestrant launch details are crucial for Roche's future. Find out what was revealed during the Q3 earnings call.
Read More
Anti-cancer drug prices: Clear savings with 70% reduction!
Anti-cancer drug prices are set to drop by 70% starting Nov 9, thanks to new government regulations capping margins at…
Read More